to show that anaesthesia-related factors have any significant impact, concluding that knowledge of patient factors (age and medical condition) and surgical-related factors are all that is necessary to predict outcome 6 ,? This may be because of the design of the outcome studies, inadequate sample size, or their interpretation.
If what we do appears unimportant, why is it useful to identify risk factors? Prediction of outcome is obviously important. More importantly, if identification and elimination of risk factors can be followed by a decrease in mortality, or if a subset of high-risk patients can be reliably identified, then they can be offered alternative treatment. Up until recently, these risk factors have been useful for prediction of group outcome, but not for the individual patient.
Goldmann and colleagues attempted this in 1977, with patients undergoing noncardiac surgery8. They studied 1001 patients in order to predict which patients were at higher risk of cardiac morbidity/mortality. Their Cardiac Risk Index (CRI) was then applied retrospectively, to divide patients into four preoperative classes (Class I-IV). Unfortunately, the original Goldmann CRI has not been shown to reliably predict outcome 9
• 1O
• Why is this so? It should be noted that outcome in the Goldmann study was only defined in terms of the cardiovascular system: 58 had cardiac deaths or major complications. It was only the characteristics of those 58 patients that were used to determine risk, yet a further 40 patients died from other causes (see below).
Summary of Statistical Tests Used
It is essential for anaesthetists interested in outcome studies to understand the basic features of the common statistical tests used in their analysis. Further techniques are used in the evaluation of the derived predictive equation, or "risk score", for patients undergoing anaesthesia. Familiar statistical procedures, such as simple linear regression, Chi square and Student's t test have been enhanced by odds ratios, multivariate logistic regression, sensitivity and specificity, positive predictive value and negative predictive value.
Analysis of outcome usually begins by defining the occurrence of a complication, or by death. Thus outcome is a categorical variable. The presence or absence of various factors, either patient, surgical or anaesthetic, can each be analysed as to their effect on outcome. When each of these prognostic factors is looked at separately, the familiar univariate Chi square analysis can be used 11. Here, a 2 by 2 contingency table is constructed and the observed and expected events are compared. This traditional significance testing will result in a probability, or "P value", which tells you the chance of the observed rate being due to chance (or more correctly, the chance of rejecting the null hypothesis, when in fact it is true-type I error).
Odds Ratio
Another method used to analyse contingency tables and one that is becoming more popular, is odds ratios (Figure 1 )12. This is an estimate of the risk of an outcome given some exposure, or risk factor. When presented with a contingency table, it has been usual practice to perform a Chi square analysis, resulting in a P value. But this only tells us whether or not the observed difference is statistically significant, not how much the groups differ. Odds ratios can give us both the statistical information and the clinically important extent of the difference. Thus if the presence of a risk factor results in an odds ratio of 1.0, then it has no significant effect on outcome. If the odds ratio is 3.0, then the patient is three times more likely to have that outcome. If the odds ratio is 0.5, then they have a 50070 reduction in risk. These odds ratios are normally presented with 95 % confidence intervals, so that if the interval includes the value 1.0, there is no significant effect at the traditional 5 % level (i.e. P is not less than 0.05). These so-called univariate techniques assess each factor in isolation and may reveal a number of significant exposures, or risk factors. Some of these risk factors will only be significant because they are associated with another important risk factor, others because of an uneven distribution of confounding factors (also known as con founders, or covariates). An example of this can be seen in Tables 1 and 2 , where the odds ratio for anaemia is 4.66 with univariate testing, but becomes 2.68 with multivariate testing; this occurs because anaemia is associated with other conditions which may adversely affect outcome (see later). To separate out the relative importance of each of these risk factors, they should then be analysed using some form of multivariate analysis. The most common method used in outcome studies is stepwise logistic regression analysis 13.
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Logistic Regression
This is a special form of regression analysis used when the outcome variable is a dichotomous (yes/no) categorical variable; that is, complication or no complication death or no death. It produces a probability of an ~utcome from 0 to 1 (Figure 2 ). The stepwise procedure is usually managed by computer softw~re and involves adding each factor separately to determme if it improves the prediction of outcome ("goodness of fit"). If further addition of factors does not improve the predictive ability of the model (given a nominated P value), then they are not included. If some of the factors are associated with each other, then only one will usually be required in the final regression equation. Thus some important factors may not appear in the final logistic regression equation, because another correlated factor is a better predictor 6 ,7. Another feature of logistic regression analysis, unlike Chi square analysis, is that the factors added to the equation. do not have to be categorical in nature; they can be ordmal or continuous. However, only dichotomous categorical factors can be expressed with odds ratios.
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Hence the odds ratio for the factor XI is equal to e{Jl. It should also be stressed that other equations, or "models", may be developed with different factors that may be equally accurate as predictors. Hence, if a factor is not in the final logistic regression equation, it may still be associated with the outcome of interest. Development of a reliable predictive model requires assistance from a statistician experienced in logistic regression techniques, because of the potential problems of, for example, correlation and interaction of factors. But it also requires involvement of an experienced clinician, as the risk factors ultimately chosen in the model must be reliable and clinically relevant. It should also be appreciated that there are many types of multivariate analyses used in outcome studies (e.g. discriminant analysis, log-linear modelling, multiple analysis of variance and covariance); these are beyond the scope of this article. The reader can be reassured that logistic regression is by far the most common technique used in outcome studies.
The exponential form of the logistic regression equation may be unwieldy to use in clinical practice, so is often converted to a risk score. Examples include the Goldmann Cardiac Risk Index 8 for patients undergoing noncardiac surgery and the Clinical Severity Score!4 for patients undergoing coronary artery surgery. Examples also exist for intensive care patients: APACHE 11, CRIB Score 1519
Once an equation or risk score is developed, it should ideally be validated prospectively on new data. This is because such risk scores will inherently perform better on the data they were derived from. Thus, the resulting risk score is in fact a diagnostic test, which may be "negative" or "positive".
Predictive or Diagnostic Tests
The utility of a diagnostic test is traditionally described by sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) ( Figure 3 The Effect of Prevalence: If the Goldmann CRI is appl~ed to 100 vascular patients with an expected rate of cardiac complications of 10% (i.e. prevalence = 10%), then PPV = 23%'6. However, if the cardiac complication rate is only 4%, then PPV = 10%. Sensitivity is the true positive rate. It is the proportion of positives that are correctly identified by the test. Specificity is the true negative rate, the proportion of negatives that are correctly identified. There is also the false positive rate (i.e. akin to type I error, or P value) and the false negative rate (the type 11 error).
A different cut-off point for a particular risk score can be chosen to represent "test positive" and "test negative' '. For example, if the Goldmann CRI score of 12 was used as the cut-off point for "test positive" and "test negative" (Class III and IV), the sensitivity becomes 55070 and the specificity 88%21. This change in sensitivity and specificity can be plotted as a receiveroperator characteristic (ROC) curve (see Swets 22 and Hanley and McNeiP' for further discussion on ROC curves). Various clinical scoring systems can also be compared using ROC curves 6 , [14] [15] [16] 18 .
Diagnostic test evaluation is commonly used by laboratory workers interested in the accuracy of their testing procedures. Hence they place more importance on sensitivity and specificity. However, anaesthetists gain greatest use from a risk score applied preoperatively, so are more interested in how predictive the test is. Thus PPV and NPV are most useful in the clinical setting.
Type 11 Error and Power
If a risk score is negative (i.e. the test predicts a good outcome) but the patient has a poor outcome (i.e. a false negative result), then a type 11 error has occurred. Type 11 error is particularly important in outcome studies because we would often like to know how likely we are to be wrong when we predict the patient will not suffer an adverse outcome. Outcome studies have been plagued by type 11 error, because the outcomes being measured (e.g. postoperative mortality or major morbidity, or failed intubation) are rare events 24 ,25. Small differences in rare but important events required extremely large sample sizes to minimize the risk of a type 11 error. Sample size calculation not only requires knowledge of the rate and expected difference, but also the nominated P value (type I error).
If the sample size of a study designed to develop a risk score is increased, the predictive ability of the resultant score will also increase. This will reduce the likelihood of a type 11 error. For traditional significance testing, the power of the test [(I-type 11 error) x 100% 1 describes the likelihood of detecting a real difference if it exists. It can also be applied to risk scores.
Outcome Studies
In the original study by Goldmann et aI., there were 58 patients with cardiac complications (i.e. pre-valence = 5.8%), 14 of whom had a cardiac risk index score over 25 (Figure 3a) 8. Hence sensitivity is only 24% with a false negative rate of 76% (the type 11 error). The specificity was 91 %, mainly because of the low rate of complications. The false positive rate was therefore 9%; this is the same as saying the P value is 0.09, traditionally considered not significant. Different cut-off points could be chosen to represent "test positive" or "test negative", but there remains a tradeoff between sensitivity and specificity.
If we now attempt to apply the Goldmann CRI to a theoretical vascular patient (assuming a cardiac complication or death rate of 10%, and similar sensitivity and specificity), then the PPV is only 33% (Figure 3b )21. Hence even in this high risk group, two out of three patients who get significant complications will not be identified by the Goldmann CRI. It is therefore not surprising that this risk index has failed to gain popularity.
Cohen and colleagues analysed the outcome of a very large Canadian cohort of 112,000 surgical patients 6 ,26.27 . A variety of patient, surgical and anaesthetic factors were collected, with outcome defined by postoperative complications and seven-day mortality. This group have published several papers on the analysis of this data set, looking at the complication rate 27 , the predictive ability of ASA status 26 and sevenday mortality rate 6 .
After univariate testing (using Chi square analysis or odds ratios), all significant factors were added to a logistic regression equation. For anaesthetists, only "narcotic alone" technique and "less anaesthetic drug use" remained independently significant. As each potential predictive factor was added to their model, it was assessed to see if it increased sensitivity and specificity. There was no increase in predictive ability after knowledge of patient and surgical factors (using ROC curves). However, although the authors failed to demonstrate that anaesthetic factors were helpful in predicting outcome, it may still be that such factors are important. Significant additional effect on predictive ability is difficult to show with such techniques, and may only be demonstrated with prospective evaluation.
Forrest and colleagues investigated whether choice of general anaesthetic agent affected outcome, using a large prospective, randomized multicentre study of 17,000 patients'S"o. The agents tested were halothane, enfiurane, isofiurane and fentanyl. Patients were followed for seven days postoperatively. Statistical analyses included Chi square analysis for the outcome categorical data. Overall mortality was 0.1 % (i.e. 19 deaths), with anaesthesia considered contributory in about 30% of these.
Importantly, the overall rates of death, myocardial infarction and stroke were so low that no conclusion could be drawn about choice of anaesthetic agent and these outcomes. If the reader concludes that choice of anaesthetic agent is not associated with these major adverse outcomes, they may expose themselves to a type 11 error. This is because of the potent influence of prevalence rates on risk prediction: an extremely large study is required to find differences in the rare yet serious outcome events such as death, myocardial infarction and stroke. In fact, you would have to study at least 200,000 patients to have a 95070 chance of finding a 50070 difference 3 1 ! The major findings of the original report were that severe ventricular arrhythmias were more common with halothane, severe hypertension and bronchospasm with fentanyl, and severe tachycardia with isoflurane. Recovery in the first 30 minutes was slowest with halothane and those that received fentanyl had less pain in the recovery room 29 • The authors concluded that significant differences in patient outcome exist between the four agents. The authors also analysed seven-day mortality and all their predictor variables using Chi square, followed by logistic regression, and found significant factors to include: cardiac failure, myocardial infarction within 12 months, ASA physical status 3 or 4, age over 50 years, cardiovascular, thoracic, abdominal or neurosurgery, and importantly for us, the anaesthetic agent used 30. The actual anaesthetic agent only had a small impact on total severe outcome, but was quite varied as to specific outcomes. They had several categories of severe outcome, with slightly different predictor variables.
The bonus of this extensive study was the inclusion of all the regression coefficients. For the first time, the chance of any particular nominated outcome could be calculated for any particular patient and surgery, and then the impact of choice of anaesthetic agent assessed. They include the example of a 60-year-old smoker with hypertension who is anaesthetised with enflurane, who has a calculated risk of severe hypertension of 0.5070 30. This will be increased to 0.7070 if halothane is used and to 2.1 070 with fentanyl. However, it must be stressed that the clinical significance of this predicted outcome then needs to be assessed by the anaesthetist.
This study needs to be interpreted with caution 11 -ll • Despite having a sample size of 17,000 patients it was not large enough to detect differences in mortality or major morbidity rates (i.e. it lacked power to detect these differences). This highlights the effect of prevalence: only 5070 of patients had a severe outcome. Most patients (about 90070) were healthy ASA 1 or 11; they may not represent the same patient population that other institutions are exposed to. It must also be remembered that their nominated severe outcomes may Anaesthesia and Intensive Care, Vol. 22, No. 4, August, 1994 not equate with clinically signifcant patient morbidity. True outcomes such as death or myocardial infarction are rare in anaesthesia, as demonstrated in this study. Therefore surrogate or intermediate outcomes are often used. This distinction must be appreciated and it should be remembered that one may not necessarily follow another. For example, is tachycardia an adverse outcome, or should we measure episodes of myocardial ischaemia (more difficult, less common), or should we really only concern ourselves with myocardial infarction or death? The role of the actual anaesthetist was also not examined; common sense tells us that experience and expertise must be important. Higgins and colleagues analysed the impact of preoperative risk factors on outcome after coronary artery surgery I' .
They first prospectively collected data on 5051 cardiac surgery patients and analysed these risk factors with univariate Chi square analysis (or Fisher's exact test) and odds ratios. This was followed by stepwise logistic regression analysis which identified 13 variables that were associated with a poor outcome. Table 1 shows the result of the initial univariate analysis. Note the potential correlation between some of these factors, such as a history of kidney disease, kidney transplant or dialysis, and elevated serum creatinine. This is an example of where multivariate logistic regression may suppress some of these in favour of the most potent risk factor. Table 2 shows the results of the logistic regression analysis, with a reduced number of significant factors. The most potent predictors were emergency surgery, renal impairment and severe left ventricular dys-function. They developed a Clinical Severity Score based on this analysis (Table 3) and then, importantly, validated this scoring system prospectively on a further 4169 patients. The sensitivity, specificity, PPV and NPV were also calculated. With a mortality score cut-off at 6, they had a sensitivity of 68070, specificity of 86%, PPV of 11 % and NPV of 99%. As stated above, the low PPV and high NPV are strongly influenced by the low mortality rate. For this reason their model is most useful in predicting a good outcome in low risk patients. Although accurate prediction of outcome in patients undergoing coronary artery surgery is still limited, closer estimates of mortality and morbidity can be made, and these may affect patient management. As the authors state, caution should be exercised, as even most of the higher risk patients survived.
CONCLUSION
We would like to emphasise that outcome studies designed to predict individual risk need to be based on very large populations. They are very expensive to fund (millions of dollars), need to be multi-centred and have had limited findings in the past, all of which reduces the success of these studies being financed from regular funding bodies, particularly in Australia. The statistical procedures employed usually include the twostep process of univariate analysis using Chi square or odds ratios, followed by multivariate analysis using stepwise logistic regression. Ideally, results should be further validated prospectively to determine the utility of the predictive scoring system put forward. It should also be remembered that an association between a risk factor and an outcome does not imply a direct causeeffect relationship; the correct method to prove this is the prospective, controlled trial.
Anaesthetic factors may be important in patient outcome; poor anaesthetic practices have not really been studied; choice of anaesthetic agent will have an impact on outcome, especially specific complications. However, the potent risk factors remain the patient's preoperative status and the type of surgery performed. This still remains important for the anaesthetist, as detection of preoperative risk factors can lead to their correction. And more accurate prediction of individual outcome can rationalise the decisions made before surgery.
